Mn Services Vermogensbeheer B.V. Buys 3,000 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mn Services Vermogensbeheer B.V. raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 139,100 shares of the medical equipment provider’s stock after acquiring an additional 3,000 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Intuitive Surgical were worth $72,605,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ISRG. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $38,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.3 %

NASDAQ:ISRG opened at $580.93 on Thursday. The stock has a market cap of $206.92 billion, a P/E ratio of 90.63, a PEG ratio of 5.85 and a beta of 1.39. The business’s 50-day moving average price is $568.10 and its two-hundred day moving average price is $527.65. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ISRG. UBS Group boosted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Evercore ISI increased their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Citigroup lifted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, CICC Research started coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,240 shares of company stock worth $3,529,040. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.